The acquisition is a small, strategic bolt-on for Pluri's food-tech subsidiary with no disclosed deal value or near-term revenue guidance. Traders should view this as a minor positive for the subsidiary's platform story but not a material catalyst for Pluri's stock given its $17M market cap. Monitor for any future revenue milestones or larger partnerships from EAF.
Price Chart
Executive Summary
Pluri's majority-owned food-tech subsidiary, Ever After Foods (EAF), has acquired Fishway BV, a Belgian aquatic cell biology and ACF media company, to expand its cultivated-protein platform. The acquisition is supported by an additional $2 million strategic investment via a SAFE agreement. This is a small-scale bolt-on acquisition for a $17M market cap company, adding niche capabilities but with no disclosed financial terms or near-term revenue impact, making it a modest strategic step rather than a transformative event.
Key Financial Metrics
Key Facts
- Ever After Foods (majority-owned by Pluri) acquired Fishway BV, a Belgium-based aquatic cell biology and ACF media company.
- EAF secured an additional $2 million strategic investment via a SAFE agreement in connection with the acquisition.
- The acquisition adds aquatic cell biology and ACF media capabilities to EAF's cultivated-protein manufacturing platform.
- No financial terms of the Fishway acquisition were disclosed beyond the $2 million SAFE investment.
- Pluri's market cap is $17M, making this a small-scale strategic move with limited immediate financial impact.
Financial Impact
$2 million SAFE investment supporting platform development; acquisition terms undisclosed
Risk Factors
- No disclosed financial terms for the Fishway acquisition, making it difficult to assess value creation.
- Cultivated-protein industry faces significant commercialization and regulatory hurdles.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3346147 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $1.05 | awaiting T+20 | — | $1.12 (−6.67%) |
Oct 16, 2026 11d ago | EFFECT | $0.9299 | awaiting T+20 | — | $1.12 (−20.44%) |
Oct 6, 2026 20d ago | S-1 | $1.04 | awaiting T+20 | — | $1.12 (+7.69%) |
Aug 28, 2026 8w ago | 424B5 | $1.53 $0.9700 | ▲ +36.60% | ▲ +36.86% | $1.12 (+26.80%) |
Aug 28, 2026 8w ago | 8-K | $1.53 $0.9700 | ▲ +36.60% | ▲ +36.86% | $1.12 (+26.80%) |
Aug 17, 2026 10w ago | 8-K | $1.63 $1.19 | ▼ −26.99% | ▼ −26.00% | $1.12 (−31.29%) |
Aug 17, 2026 10w ago | Press Release | $1.60 $1.17 | ▼ −26.61% | ▼ −24.63% | $1.12 (−30.00%) |
Jul 14, 2026 14w ago | 8-K | $1.75 $1.63 | ▲ +7.14% | ▲ +9.49% | $1.12 (+36.00%) |
Jun 22, 2026 18w ago | 8-K | $2.10 $1.82 | ▼ −13.13% | ▼ −14.29% | $1.12 (−46.54%) |
Apr 23, 2026 26w ago | DEFA14A | $3.35 $2.30 | ▼ −31.34% | ▼ −35.37% | $1.12 (−66.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers